Brian Ramjattan

869 total citations
8 papers, 354 citations indexed

About

Brian Ramjattan is a scholar working on Epidemiology, Surgery and Infectious Diseases. According to data from OpenAlex, Brian Ramjattan has authored 8 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Surgery and 1 paper in Infectious Diseases. Recurrent topics in Brian Ramjattan's work include Cervical Cancer and HPV Research (6 papers), Hepatitis B Virus Studies (5 papers) and Genital Health and Disease (3 papers). Brian Ramjattan is often cited by papers focused on Cervical Cancer and HPV Research (6 papers), Hepatitis B Virus Studies (5 papers) and Genital Health and Disease (3 papers). Brian Ramjattan collaborates with scholars based in United States, Canada and Germany. Brian Ramjattan's co-authors include Barbara Romanowski, Klaus Peters, Linda M. Ferguson, Tino F. Schwarz, Karin Schulze, Peter Hillemanns, Marc Dionne, Anne Schuind, Kurt Dobbelaere and Dominique Descamps and has published in prestigious journals such as The Journal of Infectious Diseases, BMJ Open and Journal of Pain.

In The Last Decade

Brian Ramjattan

8 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Ramjattan United States	7	262	154	54	43	30	8	354
Lene Fogt Lundbo Denmark	9	83 0.3×	29 0.2×	23 0.4×	9 0.2×	48 1.6×	21	190
Vincent Baty France	9	92 0.4×	96 0.6×	14 0.3×	47 1.1×	66 2.2×	20	271
Ofer Ben‐Bassat Israel	10	170 0.6×	86 0.6×	54 1.0×	41 1.0×	1 0.0×	22	312
Maria Giulia Demarzo Italy	9	95 0.4×	105 0.7×	58 1.1×	101 2.3×		22	281
Pierluigi Blanc Italy	9	119 0.5×	28 0.2×	12 0.2×	2 0.0×	6 0.2×	18	246
Grant Paulsen United States	8	127 0.5×	53 0.3×	11 0.2×	2 0.0×	4 0.1×	28	173
Derrick Tee Australia	8	96 0.4×	52 0.3×	72 1.3×	34 0.8×	4 0.1×	18	262
Wayne Woo United States	7	53 0.2×	21 0.1×	71 1.3×	34 0.8×	1 0.0×	12	180
Simon Jakobovits United Kingdom	5	183 0.7×	62 0.4×	16 0.3×	21 0.5×	3 0.1×	7	313
Kevin Cannon United States	6	181 0.7×	11 0.1×	22 0.4×	4 0.1×	33 1.1×	12	243

Countries citing papers authored by Brian Ramjattan

Since Specialization

Citations

This map shows the geographic impact of Brian Ramjattan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Ramjattan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Ramjattan more than expected).

Fields of papers citing papers by Brian Ramjattan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Ramjattan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Ramjattan. The network helps show where Brian Ramjattan may publish in the future.

Co-authorship network of co-authors of Brian Ramjattan

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Ramjattan. A scholar is included among the top collaborators of Brian Ramjattan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Ramjattan. Brian Ramjattan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

El‐Zein, Mariam, Agnihotram V. Ramanakumar, Paulo Naud, et al.. (2019). Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women. Sexually Transmitted Diseases. 46(10). 663–669. 10 indexed citations

Folschweiller, Nicolas, Ulrich Behre, Marc Dionne, et al.. (2019). Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine. The Journal of Infectious Diseases. 219(11). 1799–1803. 12 indexed citations

Ramanakumar, Agnihotram V., Paulo Naud, Cecília Roteli-Martins, et al.. (2016). Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial. BMJ Open. 6(8). e011371–e011371. 27 indexed citations

Romanowski, Barbara, Tino F. Schwarz, Linda M. Ferguson, et al.. (2014). Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination. Human Vaccines & Immunotherapeutics. 10(5). 1155–1165. 85 indexed citations

Schwarz, Tino F., Barbara Romanowski, Klaus Peters, et al.. (2012). O608 IMMUNE RESPONSE TO THE HPV‐16/18 AS04‐ADJUVANTED VACCINE ADMINISTERED AS A 2‐DOSE OR 3‐DOSE SCHEDULE UP TO 3 YEARS AFTER VACCINATION. International Journal of Gynecology & Obstetrics. 119(S3). 2 indexed citations

Romanowski, Barbara, Tino F. Schwarz, Linda M. Ferguson, et al.. (2011). Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule. Human Vaccines. 7(12). 1374–1386. 144 indexed citations

Irving, Gordon, Brian Ramjattan, Michael J. Cousins, et al.. (2011). A Randomized, Placebo-Controlled Phase 3 Trial (Study SB-767905/013) of Alvimopan for Opioid-Induced Bowel Dysfunction in Patients With Non-Cancer Pain. Journal of Pain. 12(2). 175–184. 59 indexed citations

Ramjattan, Brian, et al.. (2002). Efficacy and tolerability of a “suprabioavailable” formulation of fenofibrate in patients with dyslipidemia: a pooled analysis of two open-label trials. Clinical Therapeutics. 24(7). 1105–1116. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact